Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

<p>Abstract</p> <p>Background</p> <p>Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the e...

Full description

Bibliographic Details
Main Authors:	Zürbig Petra, Mischak Harald, Andersen Sten, Parving Hans-Henrik, Rossing Peter
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	BMC Nephrology
Online Access:	http://www.biomedcentral.com/1471-2369/11/29

Similar Items

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
by: Gemma E. Currie, et al.
Published: (2018-04-01)

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review
by: Frederik Persson, et al.
Published: (2016-07-01)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
by: Winther Kaj, et al.
Published: (2011-07-01)

Urinary Proteome Differences in Canine Diabetes with and without the Presence of Microalbuminuria
by: Dagmara Winiarczyk, et al.
Published: (2022-03-01)

P3.3 THE CKD273 URINARY PROTEOMIC BIOMARKER FOR EARLY DIAGNOSIS OF DIABETIC NEPHROPATHY DOES NOT INDICATE GENERALISED SUBCLINICAL VASCULAR DISEASE IN NORMOALBUMINURIC TYPE 2 DIABETIC PATIENTS
by: Gemma Currie*, et al.
Published: (2015-11-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria.
by: Christina Gjerlev Poulsen, et al.
Published: (2023-01-01)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
by: Reinhard Henrik, et al.
Published: (2011-08-01)

Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy
by: Frederik Persson, et al.
Published: (2012-03-01)

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.
by: Alaa Alkhalaf, et al.
Published: (2010-01-01)

1.4 A PROTEOMIC MARKER OF DIABETIC NEPHROPATHY IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH TYPE 2 DIABETES
by: Gemma Currie, et al.
Published: (2017-12-01)

Microalbuminuria in children with urinary tract infection
by: Byung Ok Kwak, et al.
Published: (2010-09-01)

The use of urinary proteomics in the assessment of suitability of mouse models for ageing.
by: Esther Nkuipou-Kenfack, et al.
Published: (2017-01-01)

MICROALBUMINURIA BESIDES TO URINARY ENZYMATIC PROTEIN LEVELS INCREASE IN DIABETIC KIDNEY DISEASE WITH TYPE II DIABETICS
by: Mosa F Osama, et al.
Published: (2018-08-01)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
by: Claudia Pontillo, et al.
Published: (2017-11-01)

Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology.
by: David M Maahs, et al.
Published: (2010-09-01)

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
by: Lorenzo Catanese, et al.
Published: (2023-05-01)

Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)

Systemic Inflammation Precedes Microalbuminuria in Diabetes
by: Florian G. Scurt, et al.
Published: (2019-10-01)

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients
by: Reinhard Henrik, et al.
Published: (2012-10-01)

A story of microalbuminuria and diabetic nephropathy
by: Bijan Roshan, et al.
Published: (2013-10-01)

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
by: Lorenzo Catanese, et al.
Published: (2021-07-01)

Correlation of apelin with microalbuminuria in type 2 diabetic patients
by: Shaik Johnbasha, et al.
Published: (2023-03-01)

MICROALBUMINURIA IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: ad Kadhum Hassan, et al.
Published: (2007-12-01)

Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis
by: Cermanová Melanie, et al.
Published: (2005-11-01)

Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes
by: M.C. Boelter, et al.
Published: (2006-08-01)

Duration of diabetes as an important risk factor of microalbuminuria in type 2 diabetes
by: Vitasari Indriani, et al.
Published: (2020-04-01)

P3.5 URINARY PROTEOMICS AND VASCULAR PHENOTYPING IN A COHORT OF TYPE 2 DIABETIC PATIENTS AT HIGH CARDIOVASCULAR RISK
by: G. Currie, et al.
Published: (2014-11-01)

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
by: Reinhard Henrik, et al.
Published: (2012-03-01)

Diabetic nephropathy. Is renoprotection determined by the choice of hypoglycemic therapy?
by: A. Y. Babenko, et al.
Published: (2015-12-01)

Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria
by: Ning J, et al.
Published: (2020-06-01)

The association between glycemic control and microalbuminuria in Type 2 diabetes
by: Anwar Ali Showail, et al.
Published: (2016-01-01)

The prevalence of microalbuminuria in type 2 diabetic patients in Enugu metropolis
by: I S I Ogbu, et al.
Published: (2009-01-01)

Microalbuminuria and glycated hemoglobin in children with type 1 diabetes mellitus
by: Magdy A. Omar, et al.
Published: (2015-03-01)

PREVALENCE OF MICROALBUMINURIA IN CHILDREN AND ADOLESCENTS WITH DIABETES MELLITUS TYPE I
by: H. Moayeri H. Dalili
Published: (2006-04-01)

PREVALENCE OF MICROALBUMINURIA IN CHILDREN AND ADOLESCENTS WITH DIABETES MELLITUS TYPE I
by: H. Moayeri H. Dalili
Published: (2006-06-01)

Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
by: Xiaomeng Sun, et al.
Published: (2020-05-01)

Renoprotective Effects of Trigonella foenum and Cinnamon on Type 2 Diabetic Rats
by: M.Kassaee, et al.
Published: (2017-06-01)

Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease
by: Stine E Nielsen, et al.
Published: (2013-06-01)

Association of 24-h urinary sodium excretion with microalbuminuria in a Chinese population
by: Chunxiao Xu, et al.
Published: (2023-01-01)